Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The microbiota living in gut influence the immune response, metabolism, mood and behavior. The diet plays a pivotal role in maintaining healthy gut microbiota composition and its fermentation leads to production of Short Chain Fatty Acids (SCFAs) mainly acetate, propionate and butyrate. During pancreatic dysfunction, insulin mediated suppression of glucagon is impaired leading to uncontrolled glucose production by liver and state of hyperglycemia. Insulin and glucagon balance is as important as insulin sensitivity which is reduced during Type 2 Diabetes (T2D). Glucagon like peptide-1 (GLP1) produced by Intestinal epithelial cells regulates insulin and glucagon secretion directly via GLP1 receptor on pancreatic cells or via nervous system. But half-life period of GLP1 is very short i.e. about 2 min, after which it is cleaved and inactivated. SCFAs are well documented to induce GLP1 but its direct effect on pancreatic dysfunction has not been reported. This review opens a new avenue to study the role of SCFAs as treatment to pancreatic dysfunction and T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Morrison, D. J., & Preston, T. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1134082 · Cited by 3,781
Topping, D. L., & Clifton, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1031 · Cited by 3,091
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Butyrate improves insulin sensitivity and increases energy expenditure in mice
Gao, Z., Yin, J., Zhang, J., Ward, R. E., Martin, R. J., Lefevre, M., Cefalu, W. T., & Ye, J. (2009) · Diabetes · doi:10.2337/db08-1637 · Cited by 2,204
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., et al. (2003) · Nature · doi:10.1038/nature01478 · Cited by 1,538
Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Talchai, C., Xuan, S., Lin, H. V., Sussel, L., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.07.029 · Cited by 1,415
Beta Cell Dysfunction and Insulin Resistance
Cerf, M. E. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00037 · Cited by 964
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917
Research works printed but not linked: 41
- Larsson, 2000, Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance, Diabetes Care, 23, 650, 10.2337/diacare.23.5.650 · DOI · Paper page
- Rui, 2014, Energy metabolism in the liver, Comprehensive Physiology, 4, 177, 10.1002/j.2040-4603.2014.tb00548.x · doi:10.1002/j.2040-4603.2014.tb00548.x · Paper page
- Doyle, 2007, Mechanisms of action of glucagon-like peptide 1 in the pancreas, Pharmacol Ther, 113, 546, 10.1016/j.pharmthera.2006.11.007 · DOI · Paper page
- Brown, 2012, Choosing between glp-1 receptor agonists and dpp-4 inhibitors: a pharmacological perspective, Journal of Nutrition and Metabolism, 2012, 10, 10.1155/2012/381713 · DOI
- Lin, 2012, Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms, PLoS One, 7
- Tang, 2015, Loss of ffa2 and ffa3 increases insulin secretion and improves glucose tolerance in type 2 diabetes, Nat Med, 21, 173, 10.1038/nm.3779 · DOI · Paper page
- Roy, 2006, vol. 21, 351
- Fleming, 1991, Nutrient utilization by cells isolated from rat jejunum, cecum and colon, J Nutr, 121, 869
- Yoon, 2003, Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in korea, J Clin Endocrinol Metab, 88, 2300, 10.1210/jc.2002-020735 · DOI · Paper page
- Unger, 2010, Paracrinology of islets and the paracrinopathy of diabetes, Proc Natl Acad Sci U S A, 107, 16009, 10.1073/pnas.1006639107 · DOI · Paper page
- Kawamori, 2009, Insulin signaling in alpha cells modulates glucagon secretion in vivo, Cell Metabol, 9, 350, 10.1016/j.cmet.2009.02.007 · DOI · Paper page
- Rorsman, 2008, K(atp)-channels and glucose-regulated glucagon secretion, Trends Endocrinol Metabol: TEM (Trends Endocrinol Metab), 19, 277, 10.1016/j.tem.2008.07.003 · DOI
- Kawamori, 2011, Growth factor signalling in the regulation of alpha-cell fate, Diabetes Obes Metab, 13, 21, 10.1111/j.1463-1326.2011.01442.x · DOI
- Lopez Soto, 2014, Free fatty acid receptor 3 is a key target of short chain fatty acid. What is the impact on the sympathetic nervous system?, Channels, 8, 169, 10.4161/chan.28956 · DOI
- Fu, 2013, Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes, Curr Diabetes Rev, 9, 25, 10.2174/157339913804143225 · DOI · Paper page
- Kitamura, 2013, The role of foxo1 in beta-cell failure and type 2 diabetes mellitus, Nat Rev Endocrinol, 9, 615, 10.1038/nrendo.2013.157 · DOI · Paper page
- Papa, 2012, Endoplasmic reticulum stress, pancreatic beta-cell degeneration, and diabetes, Cold Spring Harbor perspectives in medicine, 2, 10.1101/cshperspect.a007666 · DOI · Paper page
- Lee, 2010, Er stress is implicated in mitochondrial dysfunction-induced apoptosis of pancreatic beta cells, Mol Cell, 30, 545, 10.1007/s10059-010-0161-5 · DOI
- Wang, 2016, Bridges between mitochondrial oxidative stress, er stress and mtor signaling in pancreatic beta cells, Cell Signal, 28, 1099, 10.1016/j.cellsig.2016.05.007 · DOI · Paper page
- Harding, 2001, Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival, Mol Cell, 7, 1153, 10.1016/S1097-2765(01)00264-7 · DOI · Paper page
- Back, 2012, Endoplasmic reticulum stress and type 2 diabetes, Annu Rev Biochem, 81, 767, 10.1146/annurev-biochem-072909-095555 · DOI · Paper page
- Kitiphongspattana, 2007, Protective role for nitric oxide during the endoplasmic reticulum stress response in pancreatic beta-cells, Am J Physiol Endocrinol Metab, 292, E1543, 10.1152/ajpendo.00620.2006 · DOI · Paper page
- Lim, 2011, Mitochondria-targeted antioxidants protect pancreatic beta-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity, Cell Physiol Biochem: international journal of experimental cellular physiology, biochemistry, and pharmacology, 28, 873, 10.1159/000335802 · DOI · Paper page
- Rutter, 2015, Pancreatic beta-cell identity, glucose sensing and the control of insulin secretion, Biochem J, 466, 203, 10.1042/BJ20141384 · DOI · Paper page
- Li, 2008, Combination of glp-1 and sodium butyrate promote differentiation of pancreatic progenitor cells into insulin-producing cells, Tissue Cell, 40, 437, 10.1016/j.tice.2008.04.006 · DOI
- Li, 2005, Beta-cell pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1, Diabetes, 54, 482, 10.2337/diabetes.54.2.482 · DOI · Paper page
- Christensen, 2011, Histone deacetylase (hdac) inhibition as a novel treatment for diabetes mellitus, Mol Med, 17, 378, 10.2119/molmed.2011.00021 · DOI · Paper page
- Goicoa, 2006, Sodium butyrate activates genes of early pancreatic development in embryonic stem cells, Clon Stem Cell, 8, 140, 10.1089/clo.2006.8.140 · DOI
- Calanna, 2014, Alpha- and beta-cell abnormalities in haemoglobin a1c-defined prediabetes and type 2 diabetes, Acta Diabetol, 51, 567, 10.1007/s00592-014-0555-5 · DOI
- Matsuyama, 1988, Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone, Diabetes Res Clin Pract, 5, 281, 10.1016/S0168-8227(88)80063-9 · DOI
- Godoy-Matos, 2014, The role of glucagon on type 2 diabetes at a glance, Diabetol Metab Syndrome, 6, 91, 10.1186/1758-5996-6-91 · DOI · Paper page
- Nauck, 1997, Glucagon-like peptide 1 (glp-1) as a new therapeutic approach for type 2-diabetes, Exp Clin Endocrinol Diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association, 105, 187, 10.1055/s-0029-1211750 · DOI · Paper page
- Psichas, 2005, The short chain fatty acid propionate stimulates glp-1 and pyy secretion via free fatty acid receptor 2 in rodents, Int J Obes, 39, 424
- Puddu, 2014, Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes, Mediat Inflamm, 2014, 162021, 10.1155/2014/162021 · DOI · Paper page
- Perfetti, 2004, The role of glp-1 in the life and death of pancreatic beta cells, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 36, 804, 10.1055/s-2004-826167 · DOI · Paper page
- Priyadarshini, 2016, Scfa receptors in pancreatic beta cells: novel diabetes targets?, Trends Endocrinol Metabol: TEM (Trends Endocrinol Metab), 27, 653, 10.1016/j.tem.2016.03.011 · DOI · Paper page
- Wang, 2010, Cytokines in the progression of pancreatic beta-cell dysfunction, International journal of endocrinology, 2010, 515136, 10.1155/2010/515136 · DOI · Paper page
- Westwell-Roper, 2014, Is there a role for the adaptive immune system in pancreatic beta cell failure in type 2 diabetes?, Diabetologia, 57, 447, 10.1007/s00125-013-3151-2 · DOI
- Mattace Raso, 2013, Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet, PLoS One, 8, 10.1371/journal.pone.0068626 · DOI · Paper page
- Vinolo, 2011, Regulation of inflammation by short chain fatty acids, Nutrients, 3, 858, 10.3390/nu3100858 · DOI · Paper page
- Tedelind, 2007, Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease, World J Gastroenterol, 13, 2826, 10.3748/wjg.v13.i20.2826 · DOI · Paper page
Cited by
Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function
Frampton, J., Murphy, K. G., Frost, G., & Chambers, E. S. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0188-7 · Cited by 516
Dietary Fiber Intake and Gut Microbiota in Human Health
Fu, J., Zheng, Y., Gao, Y., & Xu, W. (2022) · Microorganisms · doi:10.3390/microorganisms10122507 · Cited by 394
Health Benefits of Resistant Starch: A Review of the Literature
Bojarczuk, A., Skąpska, S., Mousavi Khaneghah, A., & Marszałek, K. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105094 · Cited by 372
Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation
Akhtar, M., Chen, Y., Ma, Z., Zhang, X., Shi, D., Khan, J. A., & Liu, H. (2022) · Animal Nutrition · doi:10.1016/j.aninu.2021.11.005 · Cited by 363
Martín-Peláez, S., Fito, M., & Castaner, O. (2020) · Nutrients · doi:10.3390/nu12082236 · Cited by 330
Mazhar, M., Zhu, Y., & Qin, L. (2023) · Foods · doi:10.3390/foods12051023 · Cited by 119
The mechanism of berberine alleviating metabolic disorder based on gut microbiome
Wang, H., Zhang, H., Gao, Z., Zhang, Q., & Gu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.854885 · Cited by 69
Therapeutic Potentials of Microalgae and Their Bioactive Compounds on Diabetes Mellitus
Tamel Selvan, K., Goon, J. A., Makpol, S., & Tan, J. K. (2023) · Marine Drugs · doi:10.3390/md21090462 · Cited by 32
Metadata
- Authors
- Mandaliya, D. K., & Seshadri, S.
- Venue
- Pancreatology
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 19
- Issue
- 2
- Pages
- 280-284
- ISSN
- 1424-3903 (ISSN-L)
- OpenAlex
- W2913532408
- Cited by
- 110
- References
- 29
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- University Grant CommissionUniversity Grant Commission (UGC) (372817)
- Nirma Education and Research Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.